NICOLE FERRONI: Open Payments
NPI 1972264067 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 82 payments from 24 companies in 2025. Trend: 2023 $2,610 · 2024 $3,965 · 2025 $1,877
Food & beverage: $1,779Education: $97
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $299 |
| JAZZ PHARMACEUTICALS INC. | 5 | $165 |
| Axsome Therapeutics, Inc. | 9 | $142 |
| Vantive US Healthcare LLC | 1 | $138 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Amgen Inc. | 4 | $89 |
| Verona Pharma, Inc. | 4 | $88 |
| Lilly USA, LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Viatris Specialty LLC | 4 | $78 |
Products named: XYWAV, TEZSPIRE, Sunosi, Renal - Acute, AIRSUPRA, DUPIXENT, FASENRA, Ohtuvayre.
Industry payments across SC — which companies pay providers there.
